Loading…

Exploration of α-aminophosphonate N-derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatases

Seventeen α-aminophosphonates are synthesized. Their compositions and structures are established by EA, UV, FT-IR, 1H NMR, 13C NMR, 31P NMR and ESI-MS. Compounds 1–4 are confirmed by X-ray crystallography. PTP inhibition shows compounds 1–5, 12, 15 are moderate competitive inhibitors with some selec...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2012-03, Vol.49, p.354-364
Main Authors: Wang, Qingming, Zhu, Miaoli, Zhu, Ruiting, Lu, Liping, Yuan, Caixia, Xing, Shu, Fu, Xueqi, Mei, Yuhua, Hang, Qingwei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Seventeen α-aminophosphonates are synthesized. Their compositions and structures are established by EA, UV, FT-IR, 1H NMR, 13C NMR, 31P NMR and ESI-MS. Compounds 1–4 are confirmed by X-ray crystallography. PTP inhibition shows compounds 1–5, 12, 15 are moderate competitive inhibitors with some selectivity. The most potent inhibitor is compound 5 with the lowest IC50 value about 6.64 μM against PTP1B, about 2-fold and 25-fold stronger than against TCPTP and PTP-MEG2 while it doesn't inhibit SHP-1 and SHP-2. The binding constant of 5 to PTP1B is 2.23 × 105 M−1 and binding ratio approximates 1:1. Cell viability and apoptosis assays indicate 5 is cell permeable with lower cytotoxicity. The results indicate α-aminophosphonates are possibly developed to effective and selective inhibitors of PTPs. [Display omitted] ► New α-aminophosphonates are synthesized and characterized. ► PTP inhibition assays show 5 potently and selectively inhibits PTP1B and TCPTP. ► Compound 5 is cell permeable with lower cytotoxicity.
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2012.01.038